Let's all call AMPE and tell them to hire Rich Cavalli!
Contact info is on their webpage!
He's done more than anyone to help inflate the share price, so it would have to be in AMPE's best interest.
Never mind that he doesn't know why the Optina study is not yet listed on the FDA website, or why the Zertane study won't begin this quarter, as AMPE promised last December. And his math skills seems great!